Avatar Medical and the EIC Accelerator: Scans in 3D for Surgeons
Avatar Medical, founded in Paris in 2020, makes software that converts CT and MRI scans into interactive, photorealistic 3D models for surgeons and patients. Its EIC project described "the first photorealistic XR viewer of 3D medical images", with cloud rendering and clinical applications for orthopaedic, cancer and vascular surgery, promising hospitals productivity gains "without investing in new equipment or personnel", according to CORDIS.
The European Innovation Council granted €2,492,262 towards a €3.56 million project from June 2023 to August 2025. The report says the company completed a shoulder replacement planning platform, "brAIn Shoulder Positioning", which won FDA clearance in March 2025 and "is now commercialized in the USA through a partnership with the Medtech implant manufacturer FX Shoulder", built a cloud architecture for demanding volume rendering, and developed a way to run its viewer over hospital networks. An earlier version of its viewer, Avatar Medical Software V1, was FDA-cleared in May 2023, before the project began. In April 2026 its main product, Avatar Medical Vision, received a new FDA 510(k) clearance, which the company says makes it the first software cleared for glasses-free 3D medical displays.
Company file
- Legal entity
- Avatar Medical SAS, SIREN 885 007 112, Paris
- Founded
- 4 July 2020
- Products
- Avatar Medical Vision (CE-marked, FDA-cleared); brAIn Shoulder Positioning
- Partners
- FX Shoulder, Barco, Kyber
- Hospital users
- University of Miami Health System, Institut Curie
- EIC project
- AVATAR, 1 Jun 2023 to 31 Aug 2025, closed
- EIC funding
- Grant first
Where Avatar Medical Stands Now
In June 2026 the University of Miami Health System began deploying Eonis Vision, Avatar's software on Barco's glasses-free 3D display, in neurosurgery consultations, the first clinical installation. Institut Curie in Paris says it equipped its surgeons and radiologists with the software. In September 2026 Avatar Medical and Kyber were awarded up to €3.7 million under France 2030 to stream immersive 3D imaging anywhere in a hospital.
The record
3D medical images from VR headsets to glasses-free screens
Avatar Medical used its EIC grant to build cloud rendering, a shoulder surgery planner cleared by the FDA and an XR viewer. Its main viewer, first FDA-cleared in 2023, won a new clearance in 2026; in 2023 the company said surgeons at 20 hospitals and universities had used it.
- Jul 2020Company foundedParis
- Oct 2022EIC Accelerator cut-offAVATARgrant first
- May 2023FDA 510(k)Avatar Medical Software V1
- Jun 2023EIC project starts€3.56M project€2.49M grant
- Mar 2025Shoulder plannerFDA-cleared, sold with FX Shoulder
- Aug 2025EIC project endsCloud rendering and XR viewer delivered
- Apr 2026FDA 510(k)Avatar Medical Vision, incl. glasses-free 3D
- Jun 2026University of MiamiFirst clinical Eonis Vision deployment
- Sep 2026France 2030 awardMediVerse with Kyberup to €3.7M
CORDIS, FDA, Annuaire des Entreprises and Avatar Medical.
"We have fully completed the design, development, testing and certification (FDA clearance obtained, CE mark pending) of a software platform dedicated to shoulder arthroplasty."
Avatar Medical, report to the EICThe Technology: Seeing Anatomy Without Segmentation
Surgeons usually rely on 2D slices or simplified 3D reconstructions that lack soft tissue and vessels, the report says. Avatar's volume rendering shows full-detail 3D anatomy that can be adjusted in real time, highlighting or hiding organs, without manual segmentation. It works on standard screens, VR headsets and autostereoscopic displays, and the company says it also helps explain procedures to patients.
The approvals
Regulatory status of Avatar Medical products
1 = cleared or marked. The shoulder planner was FDA-cleared with its CE mark pending at the end of the EIC project; Avatar Medical Vision is CE-marked and FDA-cleared.
CORDIS report; Avatar Medical, April 2026.
What the EIC Project Promised, and What CORDIS Shows
The EIC project
EU contribution: 70% of a €3.6M project
The AVATAR project ran from June 2023 to August 2025. CORDIS lists it as closed. Other project costs are the CORDIS total minus the EU contribution.
CORDIS project 190147557. Values in € millions.
The project promised an XR viewer with cloud rendering and clinical applications for surgery. The report documents a commercialised shoulder planning product, cloud rendering and network distribution of the viewer, plus components for future products. The core viewer, first cleared in 2023, won a new FDA clearance in 2026 covering glasses-free 3D displays. CORDIS lists the project as closed.
- Clinical applicationDeliveredShoulder planner, FDA.
- Cloud renderingDeliveredPer report.
- XR viewer in hospitalsDeliveredMiami, Curie.
- Commercial scaleUnverifiedRevenue not published.
The Money
The French business directory shows Avatar Medical as active, with 20 to 49 employees in 2024 and no published financial data, according to Annuaire des Entreprises. The company raised a €1.2 million pre-seed round in 2021 and announced a €5 million round led by GO Capital in February 2024. The EIC award was grant first, and sources reviewed on 6 Nov 2026 show no EIC Fund investment. Its latest public funding is the France 2030 award shared with Kyber.
The public money
Public grants announced for Avatar Medical
The EIC grant, and the France 2030 award shared with Kyber (maximum shown, split not disclosed).
CORDIS; Avatar Medical, September 2026. Values in € millions.
What Cannot Be Checked
Questions for the EIC
How much Avatar Medical earns, how many hospitals pay for its software, whether it has raised money since its €5 million 2024 round and how much of the France 2030 award it receives are not public.
Why Europe Should Care
Clearer images can lead to less invasive surgery, the report argues, and help patients understand their operations. The EIC funded a Paris company that now has US clearances and partners such as Barco and FX Shoulder. Its business scale remains private.
What the project promised
The first photorealistic XR viewer of 3D medical images, with clinical applications for surgeons.
What the record shows
Two FDA-cleared products, hospital deployments and new public funding, with revenue undisclosed.
The Verdict
Delivered and cleared
Avatar Medical delivered what its EIC project report describes and won further FDA clearances. How far sales have followed is the open question.
Avatar Medical and the EIC have not been asked for comment for this article. It is based entirely on public records and published statements, linked throughout.
Sources
Industry
HealthMedical devices
- Focus
- Medical imaging
- Technologies
- Virtual reality
- 3D modelling
- Keywords
- Surgical planning
- Volume rendering
- Neurosurgery
- 3D displays